Abstract
Background
One-anastomosis gastric bypass/mini-gastric bypass (OAGB/MGB) remains controversial because it may cause chronic biliary reflux (BR). The risk of developing esogastric cancer due to BR after OAGB/MGB is based on the results of experimental rat studies using esojejunostomy (EJ). The aim of this study was to analyze the potential long-term consequences of BR on the esogastric mucosae in OAGB/MGB-operated rats and to compare these results to those from the use of EJ.
Methods
Wistar rats received OAGB/MGB (n = 16), EJ (n = 16), and sham (n = 8) operations. Mortality and weight changes were evaluated throughout the experiment. BR was measured using magnetic resonance imaging (MRI). Rats received follow-ups for 30 weeks. A double-blinded histological analysis was performed in the esogastric segments.
Results
BR was diagnosed in OAGB/MGB and EJ rats using the MRI technique; no BR occurred in the sham group. After a 30-week follow-up, no incidences of dysplasia or cancer were observed in the three groups. Additionally, esophageal intestinal metaplasia and mucosal ulcerations were observed in 41.7% and 50% of EJ rats, respectively, and no incidences of these conditions were observed in OAGB/MGB and sham rats. The incidence of esophagitis was significantly higher and more severe in the EJ group compared to those in the OAGB/MGB and sham groups (EJ = 100%, OAGB/MGB = 16.7%, sham = 8.3%; p < 0.001).
Conclusions
After a 30-week follow-up period, OAGB/MGB rats did not develop any precancerous or cancerous lesions when more than 40% of EJ rats had intestinal metaplasia.
Similar content being viewed by others
References
Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet Lond Engl. 2011;377:557–67.
Ribaric G, Buchwald JN, McGlennon TW. Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg. 2014;24:437–55.
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet Lond Engl. 2015;386:964–73.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.
Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.
Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515–29.
DeMaria EJ, Sugerman HJ, Kellum JM, et al. Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity. Ann Surg. 2002;235:640–5. discussion 645-647
Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11:276–80.
Lee W-J, Yu P-J, Wang W, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg. 2005;242:20–8.
Lee W-J, Ser K-H, Lee Y-C, et al. Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012;22:1827–34.
Chevallier JM, Arman GA, Guenzi M, et al. One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy. Obes Surg. 2015;25:951–8.
Bruzzi M, Rau C, Voron T, et al. Single anastomosis or mini-gastric bypass: long-term results and quality of life after a 5-year follow-up. Surg Obes Relat Dis. 2015;11:321–6.
Rutledge R, Walsh TR. Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg. 2005;15:1304–8.
Noun R, Skaff J, Riachi E, et al. One thousand consecutive mini-gastric bypass: short- and long-term outcome. Obes Surg. 2012;22:697–703.
Musella M, Susa A, Greco F, et al. The laparoscopic mini-gastric bypass: the Italian experience: outcomes from 974 consecutive cases in a multicenter review. Surg Endosc. 2014;28:156–63.
Kular KS, Manchanda N, Rutledge R. Analysis of the five-year outcomes of sleeve gastrectomy and mini gastric bypass: a report from the Indian sub-continent. Obes Surg. 2014;24:1724–8.
Ruiz-Tovar J, Carbajo MA, Jimenez JM, et al. Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities. Surg Endosc. 2019;33:401–10.
Bruzzi M, Chevallier J-M, Czernichow S. One-anastomosis gastric bypass: why biliary reflux remains controversial? Obes Surg. 2017;27:545–7.
Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet Lond Engl. 2019;393:1299–309.
Mariette C, Piessen G, Leteurtre E, et al. Activation of MUC1 mucin expression by bile acids in human esophageal adenocarcinomatous cells and tissues is mediated by the phosphatidylinositol 3-kinase. Surgery. 2008;143:58–71.
Greene CL, Worrell SG, DeMeester TR. Rat reflux model of esophageal cancer and its implication in human disease. Ann Surg. 2015;262:910–24.
Gronnier C, Bruyère E, Piessen G, et al. Operatively induced chronic reflux in rats: a suitable model for studying esophageal carcinogenesis? Surgery. 2013;154:955–67.
Nishijima K, Miwa K, Miyashita T, et al. Impact of the biliary diversion procedure on carcinogenesis in Barrett’s esophagus surgically induced by duodenoesophageal reflux in rats. Ann Surg. 2004;240:57–67.
Bruzzi M, Duboc H, Gronnier C, et al. Long-term evaluation of biliary reflux after experimental one-anastomosis gastric bypass in rats. Obes Surg. 2017;27:1119–22.
M’Harzi L, Bruzzi M, Chevallier J-M, Douard R. One anastomosis gastric bypass and esojejunostomy in rats: surgical techniques. MIS J [Internet]. 2019 [cited 2019 Oct 7]; Available from: https://misjournal.net/article/view/3222
Clément O, Siauve N, Lewin M, et al. Contrast agents in magnetic resonance imaging of the liver: present and future. Biomed Pharmacother Biomed Pharmacother. 1998;52:51–8.
Cavin J-B, Voitellier E, Cluzeaud F, et al. Malabsorption and intestinal adaptation after one anastomosis gastric bypass compared with Roux-en-Y gastric bypass in rats. Am J Physiol Gastrointest Liver Physiol. 2016;311:G492–500.
Cavin J-B, Couvelard A, Lebtahi R, et al. Differences in alimentary glucose absorption and intestinal disposal of blood glucose after Roux-en-Y Gastric Bypass vs sleeve gastrectomy. Gastroenterology. 2016;150:454–464.e9.
Tessier R, Ribeiro-Parenti L, Bruneau O, et al. Effect of different bariatric surgeries on dietary protein bioavailability in rats. Am J Physiol Gastrointest Liver Physiol. 2019;317:G592–601.
Quinn R. Comparing rat’s to human’s age: how old is my rat in people years? Nutr Burbank Los Angel Cty Calif. 2005;21:775–7.
Thrift AP, Shaheen NJ, Gammon MD, et al. Obesity and risk of esophageal adenocarcinoma and Barrett’s esophagus: a Mendelian randomization study. J Natl Cancer Inst. 2014;106(11). https://doi.org/10.1093/jnci/dju252.
Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet Lond Engl. 2008;371:569–78.
Hyun JJ, Yeom SK, Shim E, et al. Correlation between bile reflux gastritis and biliary excreted contrast media in the stomach. J Comput Assist Tomogr. 2017;41:696–701.
Sifrim D, Castell D, Dent J, et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004;53:1024–31.
Ireland AP, Peters JH, Smyrk TC, et al. Gastric juice protects against the development of esophageal adenocarcinoma in the rat. Ann Surg. 1996;224:358–70. discussion 370-371
Nasr AO, Dillon MF, Conlon S, et al. Acid suppression increases rates of Barrett’s esophagus and esophageal injury in the presence of duodenal reflux. Surgery. 2012;151:382–90.
Author information
Authors and Affiliations
Contributions
Leïla M’Harzi, Jean-Marc Chevallier, Gabriel Rahmi, Olivier Clement, Richard Douard, Bertrand Tavitian, and Matthieu Bruzzi designed the experiments.
Leïla M’Harzi, Anais Certain, Gwennhael Autret, Guillaume Levenson, and Matthieu Bruzzi performed the experiments.
Leïla M’Harzi and Matthieu Bruzzi performed animal surgeries.
Gwennhael Autret, Olivier Clement, and Bertrand Tavitian supervised radiologic analyses.
Anais Certain and Chloe Broudin supervised histologic analyses.
Leïla M’Harzi, Gwennhael Autret, David Louis, Tigran Poghosyan, Arthur Berger, Gabriel Rahmi, Olivier Clement, Richard Douard, Bertrand Tavitian, and Matthieu Bruzzi analyzed and interpreted data.
Leila M’Harzi and Matthieu Bruzzi wrote the manuscript with comments from Jean-Marc Chevallier, Tigran Poghosyan, Gabriel Rahmi, Richard Douard, and Bertrand Tavitian.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
All applicable institutional and/or national guidelines for the care and use of animals were followed. All experiments were performed in compliance with the European Community guidelines and approved by the Institutional Animal Care and Use Committee.
Statement of Informed Consent
Informed consent does not apply.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
M’Harzi, L., Chevallier, JM., Certain, A. et al. Long-Term Evaluation of Biliary Reflux on Esogastric Mucosae after One-Anastomosis Gastric Bypass and Esojejunostomy in Rats. OBES SURG 30, 2598–2605 (2020). https://doi.org/10.1007/s11695-020-04521-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-020-04521-4